Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoblastic Lymphoma (LBL)”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Looking for participantsNCT07070219
What this trial is testing

CTD402 in T-ALL/LBL Patients

Who this might be right for
Acute Lymphocytic Leukemia RefractoryLymphoma, Lymphoblastic
BIOHENG THERAPEUTICS US LLC 54
Testing effectiveness (Phase 2)Ended earlyNCT02257684
What this trial is testing

A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals 4
Very early researchStudy completedNCT05716113
What this trial is testing

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsNeoplasms by Site+1 more
He Huang 20
Large-scale testing (Phase 3)Looking for participantsNCT04043494
What this trial is testing

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

Who this might be right for
Lymphoblastic Lymphoma, Childhood
University Hospital Muenster 683
Testing effectiveness (Phase 2)Looking for participantsNCT04315324
What this trial is testing

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

Who this might be right for
Recurrent T Acute Lymphoblastic LeukemiaRefractory T Acute Lymphoblastic LeukemiaRefractory T Lymphoblastic Lymphoma+1 more
SWOG Cancer Research Network 67
Early research (Phase 1)WithdrawnNCT05170828
What this trial is testing

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesT-lymphoblastic Lymphoma+4 more
Ossium Health, Inc.
Not applicableStudy completedNCT00866671
What this trial is testing

Observational Study of Nelarabine in Children and Young Adults

Who this might be right for
Leukaemia, Lymphoblastic, Acute
GlaxoSmithKline 28
Early research (Phase 1)Looking for participantsNCT07280494
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Who this might be right for
CD7+ T-ALL/LBL
Peking University People's Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06918431
What this trial is testing

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma
City of Hope Medical Center 53
Testing effectiveness (Phase 2)Study completedNCT00199030
What this trial is testing

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

Who this might be right for
Adult Acute Lymphocytic Leukemia T-cellLymphoma, Lymphoblastic
Goethe University 8
Testing effectiveness (Phase 2)Study completedNCT00003545
What this trial is testing

506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861348
What this trial is testing

Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute
First Affiliated Hospital of Zhejiang University 23
Testing effectiveness (Phase 2)Looking for participantsNCT06742463
What this trial is testing

VHAG in Treating R/R T-ALL/LBL

Who this might be right for
Acute T Lymphpblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang University 50
Testing effectiveness (Phase 2)Ended earlyNCT05464836
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

Who this might be right for
Leukemia, LymphoblasticLeukemia
M.D. Anderson Cancer Center 2
Not applicableNot Yet RecruitingNCT06741813
What this trial is testing

Allo-HSCT vs ASCT in Adult T-LBL

Who this might be right for
T Lymphoblastic Lymphoma
Peking University People's Hospital 230
Large-scale testing (Phase 3)Looking for participantsNCT05681260
What this trial is testing

Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

Who this might be right for
T-cell Lymphoblastic Lymphoma
Children's Cancer Group, China 200
Post-approval studies (Phase 4)Study completedNCT00199017
What this trial is testing

German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults

Who this might be right for
Lymphoma, Lymphoblastic
Johann Wolfgang Goethe University Hospital 75
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Large-scale testing (Phase 3)UnknownNCT04446130
What this trial is testing

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Who this might be right for
Induction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)UnknownNCT05598593
What this trial is testing

Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

Who this might be right for
Cytarabine+Thiotepa + Fludarabine + BusulfanT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 70
Load More Results